Role of Managed Care and Specialty Pharmacy in Treatment of Hemophilia Patients
NHF 2015 (Dallas, August 13-15) Individualized treatment for patients with hemophilia is very important. Many groups including health care professionals (HCPs), payers and specialty pharmacies are involved in providing care.More
Basics of Clinical Trials
NHF 2015 (Dallas, August 13-15) Clinical trials are research studies that evaluate whether a drug (treatment) is safe and effective for humans.More
Distinguishing between Signs of a Bleeding Disorder and Abuse
NHF 2015 (Dallas, August 13-15) Healthcare professionals are suggesting that guidelines should be developed to compare the frequency of intracranial hemorrhages and bleeding patterns in a particular bleeding disorder to a patient’s presentation.More
Women with Bleeding Disorders
NHF 2015 (Dallas, August 13-15) The most common bleeding disorder in women and girls is von Willebrand disease, an inherited disorder that is caused by a defect or deficiency in von Willebrand factor, a protein the blood needs for clottingMore
Balance Dysfunction and Falls Risks
NHF 2015 (Dallas, August 13-15) Since people with hemophilia are gradually entering the 65 and over age group, it is very important to be screened for fall risks and to be educated on preventing falls.More
Hemophilia and the Aging Community
NHF 2015 (Dallas, August 13-15) As more hemophilia patients are living longer, they are beginning to develop various conditions that are associated with aging such as cardiovascular disease and falls leading to fracturesMore
Telemedicine: What is it and how is it useful to me?
NHF 2015 (Dallas, August 13-15) So, next time when you are worried about not being able to make it to your health appointment, remember to ask your healthcare provider about telemedicineMore
What is Half-Life and Why Do I Need to Understand It?
NHF 2015 (Dallas, August 13-15) The concept of half-life is important to understand because it determines the dosing schedule of a drug.More